Category: News

This year’s Party with a Purpose, hosted by the Friends of the AACR Foundation, will honor Robert H. Vonderheide, MD, DPhil, FAACR, and Andrew Rech, MD, PhD, of the University of Pennsylvania, for their achievements and ongoing efforts to advance cancer immunotherapy research. Learn more about their mentor-mentee relationship and their current research.

The post Party With a Purpose Honors the Power of Immunotherapy appeared first on American Association for Cancer Research (AACR).

In contrast with many cancers, uterine cancer incidence and mortality are on the rise. The disease, which is a leading cause of death among gynecologic cancers in the United States, is also associated with deep racial disparities, disproportionately affecting Black women. Elizabeth M. Swisher, MD, the 2026-2028 Chair of the AACR Cancer Prevention Working Group (CPWG) steering committee, discussed risk factors, warning signs, and the urgent need for increased public awareness and research funding.

The post Shining a Light on Uterine Cancer: Rising Incidence and Mortality, Persistent Inequities appeared first on American Association for Cancer Research (AACR).

The September Editors’ Picks from AACR’s peer-reviewed journals include insights into cancer evolution in leukemia, a strategy for overcoming drug resistance, the impacts of the COVID-19 pandemic on cancer care, an investigational treatment for triple-negative breast cancer, and more.

The post Editors’ Picks, September 2026: Drug Resistance, Breast Cancer Treatment, COVID-19 and Cancer Care, and More appeared first on American Association for Cancer Research (AACR).

In memory of those who lost their lives or families as a result of what happened on September 11, 2001, this edition of Cancer Research Catalyst reviews the effects of the attacks and showcases the new research being conducted in the 9/11-responder population.

The post The Cancer Aftermath of the 9/11 Attacks on First Responders appeared first on American Association for Cancer Research (AACR).

Tsedey Tsegaye had her sights on a career in health communication—until a civil war upended her life. A scholarship from AACR CEO Margaret Foti, through the Margaret Foti Foundation, gave her another chance to reclaim her dream and ultimately pursue a career that aims to make a meaningful contribution to cancer prevention, research, health communication, and cancer informatics.

The post ‘It Restored My Hope’: How the Margaret Foti Scholarship Helped Tsedey Tsegaye Reclaim Her Future appeared first on American Association for Cancer Research (AACR).

Recent reporting and rumors may have one believe that cigarettes are cool and popular again among young Americans. The data don’t bear this out—fewer young people smoke than ever—but a reminder of smoking’s dangers nevertheless feels warranted.

The post A Reminder: Smoking Still Causes Cancer appeared first on American Association for Cancer Research (AACR).

The AACR Project GENIE Data Model, recently released by the AACR GENIE consortium, is an open-access tool designed to help simplify data harmonization in precision oncology. Learn more about the development of the model, how it can help cancer researchers, and future plans for its expansion

The post Harmonizing Data Collection for Precision Oncology: AACR Project GENIE® Data Model appeared first on American Association for Cancer Research (AACR).

Cancer Research Catalyst has launched a new monthly series, “Unboxing Cancer News,” that highlights exciting cancer research discoveries. Read the first installment and learn about transmissible cancer in catfish, federal- vs. industry-sponsored trials, symptoms that may predict early-onset colorectal cancer, and engineered yeast that produce ingredients to make chemotherapy drugs.

The post Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More   appeared first on American Association for Cancer Research (AACR).

Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets the RAS family of proteins. Catch up on the amazing progress scientists have made in targeting RAS by reading the AACR blog’s extensive coverage of the field, from the discovery of RAS as an oncogene to the development of drugs targeting this once-elusive protein and the new advances on the horizon.

The post Breaking News: Daraxonrasib Approved for Pancreatic Cancer appeared first on American Association for Cancer Research (AACR).

Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and some of the latest approaches that strive to overcome these hurdles. Learn about recent efforts to prevent T-cell exhaustion, infiltrate the tumor microenvironment of solid tumors, shorten the manufacturing time, and more.

The post Driving CAR T-cell Therapy in New Directions appeared first on American Association for Cancer Research (AACR).